Carbocisteine

Carbocisteine (CAS No.: 638-23-3) is a small-molecule mucolytic agent widely utilized as a biochemical tool for investigating mucus regulation, inflammatory signaling, and oxidative stress pathways in respiratory-related research models. It is characterized by its ability to modulate mucus rheology through alteration of glycoprotein structure and secretion, thereby providing a useful experimental probe for studying mucus accumulation and clearance mechanisms in epithelial cell systems. At the molecular level, Carbocisteine has been shown to attenuate phosphorylation of NF-κB p65 and ERK1/2, while influencing the crosstalk between Nrf2/HO-1 and NF-κB signaling pathways, indicating roles in the regulation of inflammation, redox homeostasis, and cellular stress responses; it has also been reported to inhibit apoptosis under certain experimental conditions. These activities are typically observed in vitro at concentrations ranging from low micromolar to higher micromolar levels, depending on the assay system and biological context. Carbocisteine is frequently applied in studies employing airway epithelial cells, macrophage models, and animal systems designed to investigate mucus hypersecretion, inflammatory signaling cascades, and oxidative injury, with dosing and exposure parameters tailored to specific experimental objectives. Its well-characterized pharmacological profile and multi-pathway modulatory effects make it a valuable reference compound in drug discovery efforts targeting respiratory pathophysiology and inflammation-associated signaling networks.